Arcus Biosciences, Inc. (RCUS)

NYSE: RCUS · IEX Real-Time Price · USD
+0.03 (0.17%)
Mar 27, 2023, 4:00 PM EDT - Market closed

Total Valuation

RCUS has a market cap or net worth of $1.29 billion. The enterprise value is $279.65 million.

Market Cap 1.29B
Enterprise Value 279.65M

Important Dates

The next earnings date is Monday, May 8, 2023, after market close.

Estimated Earnings Date May 8, 2023
Ex-Dividend Date n/a

Share Statistics

RCUS has 73.01 million shares outstanding. The number of shares has decreased by -2.70% in one year.

Shares Outstanding 73.01M
Shares Change (YoY) -2.70%
Shares Change (QoQ) +0.70%
Owned by Insiders (%) 28.71%
Owned by Institutions (%) 75.90%
Float 49.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.51
Forward PS 7.01
PB Ratio 1.96
P/FCF Ratio 2.98
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.50
EV / EBIT n/a
EV / FCF 0.65

Financial Position

The company has a current ratio of 5.53

Current Ratio 5.53
Quick Ratio 5.43
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -36.80% and return on invested capital (ROIC) is -25.50%.

Return on Equity (ROE) -36.80%
Return on Assets (ROA) -18.50%
Return on Capital (ROIC) -25.50%
Revenue Per Employee $306,011
Profits Per Employee -$729,508
Employee Count 366
Asset Turnover 0.08
Inventory Turnover n/a


In the past 12 months, RCUS has paid $1.00 million in taxes.

Income Tax 1.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -51.96% in the last 52 weeks. The beta is 0.88, so RCUS's price volatility has been lower than the market average.

Beta (1Y) 0.88
52-Week Price Change -51.96%
50-Day Moving Average 19.27
200-Day Moving Average 24.44
Average Volume (30 Days) 1,127,243

Short Selling Information

The latest short interest is 6.67 million, so 9.13% of the outstanding shares have been sold short.

Short Interest 6.67M
Short Previous Month 6.51M
Short % of Shares Out 9.13%
Short % of Float 13.53%
Short Ratio (days to cover) 6.91

Income Statement

In the last 12 months, RCUS had revenue of $112.00 million and -$267.00 million in losses. Loss per share was -$3.71.

Revenue 112.00M
Gross Profit 112.00M
Operating Income -280.00M
Pretax Income -266.00M
Net Income -267.00M
EBITDA -252.00M
EBIT -266.00M
Loss Per Share -$3.71
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 1.01B
Total Debt n/a
Net Cash 1.01B
Net Cash Per Share $13.82
Equity / Book Value 657.00M
Book Value Per Share 9.00
Working Capital 874.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $438.00 million and capital expenditures -$6.00 million, giving a free cash flow of $432.00 million.

Operating Cash Flow 438.00M
Capital Expenditures -6.00M
Free Cash Flow 432.00M
FCF Per Share $6.00
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -250.00% and -238.39%.

Gross Margin 100.00%
Operating Margin -250.00%
Pretax Margin -237.50%
Profit Margin -238.39%
EBITDA Margin -225.00%
EBIT Margin -237.50%
FCF Margin 385.71%

Dividends & Yields

RCUS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -20.72%
FCF Yield 33.52%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield 2.70%
Shareholder Yield 2.70%
Dividend Details

Analyst Forecast

The average price target for RCUS is $44.29, which is 150.94% higher than the current price. The consensus rating is "Buy".

Price Target $44.29
Price Target Difference 150.94%
Analyst Consensus Buy
Analyst Count 19
Revenue Growth Forecast (5Y) 41.66%
EPS Growth Forecast (5Y) -3.21%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a